Abstract
Although many studies have shown that drug delivery and efficacy can be improved by nano-sized drug carriers, we understand little regarding their pharmacokinetics (PK). PK calculations for drugs delivered by carriers are more complex than those for drug-only solutions. The overall PK depends on many factors, including drug-release rate and the PK of both the drug itself and the carrier. We built a mathematical model to describe the intracellular PK of paclitaxel delivered by nanoparticles. Paclitaxel was incorporated into poly (lactic-co-glycolic acid) nanoparticles, which were chemically labeled with a fluorescence probe for quantification. PK profiles of drug alone, nanoparticles alone, and drug delivered by nanoparticles were studied in human breast cancer MCF7 cells. Simulated results from the model were similar to observed data, indicating that the model was properly developed. The model clearly and quantitatively represented the effects of relative factors, such as drug dose, drug-release kinetics, and nanoparticle PK, on the PK of paclitaxel delivered by nanoparticles. We also used this model to estimate the intracellular drug-release rate, which was found to be slightly slower than the in vitro release rate in this stu...Continue Reading
References
Sep 3, 2002·Advanced Drug Delivery Reviews·Irène BriggerPatrick Couvreur
Oct 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cristina FonsecaRogério Gaspar
Dec 20, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Mu, S S Feng
Mar 7, 2003·Nature·Sean D Conner, Sandra L Schmid
Aug 24, 2004·Cancer Chemotherapy and Pharmacology·Klaus MrossChristine E Swenson
May 13, 2006·Journal of Biomaterials Science. Polymer Edition·Carlos E Astete, Cristina M Sabliov
Jul 20, 2007·Acta Biomaterialia·J Zhang, R D K Misra
Jun 17, 2008·Biotechnology and Bioengineering·D Ece GamsizRebecca L Carrier
Aug 30, 2008·Trends in Biotechnology·Kathleen F Pirollo, Esther H Chang
Oct 16, 2010·ACS Nano·Mingguang LiJoshua Reineke
May 24, 2011·Toxicology Letters·Guangping XieGaoren Zhong
Jun 3, 2011·Mathematical Biosciences and Engineering : MBE·Rebeccah E MarshKenneth J E Vos
Jul 12, 2011·Nanoscale·Zhiqin ChuQuan Li
Mar 16, 2012·International Journal of Nanomedicine·Mingguang LiJoshua Reineke
Sep 15, 2012·Methods in Molecular Biology·Mingguang Li, Joshua Reineke
Oct 3, 2012·Advanced Drug Delivery Reviews·Shi XuSarah F Hamm-Alvarez
Mar 21, 2013·Molecular Pharmaceutics·Abdul Khader Mohammad, Joshua J Reineke
Citations
Feb 2, 2016·Nanomedicine·Louis T CurtisHermann B Frieboes
Mar 26, 2016·European Physical Journal Plus·Christopher G EnglandHermann B Frieboes
Apr 23, 2016·Journal of Nanobiotechnology·Lee B SimsJill M Steinbach-Rankins
Dec 15, 2015·PloS One·Louis T CurtisHermann B Frieboes
Mar 31, 2018·Pharmaceutical Research·Matshawandile TukululaAdmire Dube
Dec 31, 2015·Cancer Informatics·Hermann B FrieboesParag Mallick
Sep 6, 2018·The Journal of Pharmacy and Pharmacology·Juan I PesoaLuciano N Mengatto
Nov 28, 2019·Pharmaceutical Research·Hunter A Miller, Hermann B Frieboes
Sep 26, 2020·Frontiers in Bioengineering and Biotechnology·Hermann B FrieboesBiana Godin
Oct 10, 2018·Annals of Biomedical Engineering·Hunter A Miller, Hermann B Frieboes
Nov 12, 2018·Journal of Pharmaceutical Sciences·Nan ZhengJiafu Ji
Jan 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Julia Jiménez-LópezJosé Prados